IPO Guru
Upcoming Opens 14 Oct 2026

Fusion CX IPO GMP Today – Live Grey Market Premium

As of 9 Oct 2026, 10:12 AM IST, Fusion CX IPO GMP is ₹0, meaning no premium over the ₹289 upper price band. Kostak: not available. Subject to Sauda: not available.

Fusion CX IPO is scheduled to open for subscription on October 14, 2026. The public issue aims to raise around ₹702 Cr. and is offered in a price band of ₹275 to ₹289 per share, with a market lot of 51 shares. The day-wise GMP trend is below.

Abhishek Vohera, Founder of IPO Guru Researched & reviewed by Abhishek Vohera, Founder, IPO Guru Last updated Figures sourced from the RHP, BSE & NSE

GMP trend

Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 9 Oct, 10:12 AM IST.

Peak GMP
₹0
09 Oct 2026
Lowest GMP
₹0
09 Oct 2026
Direction
— stable
Latest day vs the day before

Day-wise GMP

The last reading of each day, newest first. Arrows compare with the previous day.

Date GMP ↑↓ % Kostak Sub. Sauda
09 Oct 2026 ₹ 0 — 0% — —

Fusion CX IPO dates

Key dates from opening to listing. Today is 9 October.

Key dates Opens soon
  1. Open 14 Oct 2026
  2. Close 16 Oct 2026
  3. Allotment 19 Oct 2026
  4. Refund/credit 21 Oct 2026
  5. Listing 22 Oct 2026

Fusion CX IPO expected listing price

Upper price band plus today's grey market premium.

Issue price (upper band)₹289
Current GMP₹ 0
Listing date22 Oct, 2026
GMP-based listing estimate Not yet available

Disclaimer: The listing price estimate above is based purely on the current grey market premium (GMP) and is not a guaranteed prediction. GMP is an unofficial, unregulated indicator and can change significantly in the 24–48 hours before listing. Do not make investment decisions based solely on GMP.

Is Fusion CX IPO GMP reliable?

Grey market premium for Fusion CX IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:

  • 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
  • 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
  • 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
  • 04Cross-check before acting: Review the Fusion CX IPO full review for a fundamentals-based assessment before making any grey market trades.

Fusion CX IPO Kostak rate explained

Two ways the grey market trades an IPO application before listing.

Kostak
Not available

The Kostak rate for Fusion CX IPO is not available. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.

Subject to Sauda
Not available

The Subject to Sauda price is not available. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.

Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.

About Fusion CX IPO

Fusion CX Limited was incorporated in 2004. It provides customer experience (CX) services in many languages across voice, chat, email, social media and messaging. Its services include customer acquisition, customer service, order fulfilment support, payments and collections, customer retention and technical support. Through its subsidiary Omind Technologies, it builds its own tools in conversational AI, marketing AI, quality automation and workforce management. It charges clients on fixed-fee, transaction-based or outcome-based models. As of 31 December 2024, it ran 40 delivery centres across 15 countries in 28 languages. As of 31 March 2026, it had 13,357 employees in its CX business. By vertical, telecom and technology gave 47.34% of FY2026 revenue from operations, BFSI 13.52%, healthcare 13.14% and consumer and retail 12.12%. By geography, the US and Canada gave 85.26%, India 11.29% and the UK and Europe 3.11%.

View full IPO details →

Frequently asked

What is the GMP of Fusion CX IPO?

The current Grey Market Premium (GMP) of Fusion CX IPO is not yet started or active in the market.

What is the Kostak Price of Fusion CX IPO?

Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Fusion CX IPO is not available.

What is the Subject to Sauda Price of Fusion CX IPO?

Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.

What is the expected listing price of Fusion CX IPO based on GMP?

The listing price estimate is not yet available as GMP has not been established for Fusion CX IPO. Check back closer to the subscription date.

Is the GMP of Fusion CX IPO increasing or decreasing?

The GMP of Fusion CX IPO is currently stable. Track the day-wise GMP table above for the latest movement.

Explore Fusion CX IPO further

The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.

Opens 14 October 2026

GMP is a mood, not a forecast.

IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.

Join the WhatsApp channel All live IPO GMP

Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.

GMP
₹ 0
Kostak
—
Est. listing
TBA
Full IPO details